Top Glove: do fundamentals back the industry rally or it is the pricing overstretch?
Since I am now back in Malaysia, I have been constantly bombarded by news about the glove makers in Malaysia. Almost a news article about them from each local news-source and it even broke to the Financial Times. So I thought I’d look into the hype and see what it is all about myself.
My narrative of Top Glove
My story for Top Glove is this. Top Glove is the biggest
pure-play glove manufacturer in the world. The company operates in Asia and
mostly locally, in Malaysia. The company has seen a spurt of growth from the
coronavirus pandemic as demand jumps for disposable medical supplies. Due to
the commodity nature of its business, most of the growth and profitability will
be experienced this year. Supply will meet with demand with high levels of
competition in the next few years, causing the company to converge back to the
industry.
Medical gloves are a commodity
During the height of the coronavirus panic, hygiene supplies
were selling at absurd prices which were contributed by the demand surge, which
was exacerbated by the hoarding and supply shock from the lockdown. As factories
reopen, pricing for medical gloves has come down. If you don’t trust me, search
for medical gloves on Lazada. The industry is also competitive. Sixteen
publicly traded companies produce medical gloves primarily, most of them operate
out of Asia. Almost half of them alone are Malaysian-based. Despite the fact,
Top Glove still has above-average profitability before the pandemic, indicating
the efficiency of management.
News article: Glove Demand-Supply Imbalance to Normalise
Data: rubber glove comp
A majority of the company’s sales come from Malaysia and most of, if not all, of it other sales comes from within Asia. |
Stories to numbers
I took my narrative for the company and compared it to the
management and the (bursa)streets. It turns out that I have the highest expectation
among them. Management tends to be conservative, while analyst consensus tends
to be upward bias. But it didn’t matter in this valuation, as the market is pricing
in an unimaginable amount of growth. I wonder if the momentum has gone out of
hand.
July 12, 2020: You could argue that the WACC could be lower or some other drivers could be better. I have included my model, use it, change the assumptions to fit your story. Credits to Aswath again.
July 12, 2020: You could argue that the WACC could be lower or some other drivers could be better. I have included my model, use it, change the assumptions to fit your story. Credits to Aswath again.
Metrics
|
Management
|
Consensus
|
ZacSeng
|
Market
|
Revenue growth, average 2020-2024
|
12.1%
|
15.2%
|
22.0%
|
116.5%
|
EBIT margins, average 2020-2024
|
19.4%
|
18.9%
|
19.4%
|
19.4%
|
Est. share price
|
2.76
|
3.05
|
3.34
|
21.18
|
Model adapted from Damodaran: TOPGLOV_dcfmodel_july20
The consensus of analyst estimates for Top Glove. Source: Bloomberg |
Why is there a big difference between intrinsic value and market price?
Interest rates around the world are falling; Malaysia is no
different. The Malaysian 10-year bond has fallen to 2.63%. This low-interest-rate
environment will ultimately nudge investors to redeploy capital into investments
with relatively higher returns, namely equities. The problem is that most of
the industries in Malaysia have been hit hard by the pandemic, negatively
impacting their future cash flows. Because of this, Malaysian investors,
especially retail investors, move their capital into “winner” stocks like Top
Glove and the momentum starts to snowball.
31% of the shares of Top Gloves are
held by retail investors. Source: Capital IQ
|
Conclusion
I think the company is overhyped and overvalued. Don’t get me
wrong, Top Glove is a decent company, it was the fastest to scale up its
production and is the more efficiently-run company. But even a great company
does not necessarily translate to a good investment if it is not valued
attractively. I suspect that a lot of the stocks that were hit in the past months
will now be good investments as they are now significantly undervalued as how
Top Glove is overvalued.
What am I going to do with this? I would normally short sell the company if I can. But at the moment Bursa Malaysia has conveniently banned short-selling until the end of the year. I will reserve the ban for another rant, but that is my take on the medical glove industry and particularly Top Glove.
What are your thoughts on this? Has the momentum gone out of
hand and into bubble territory?
Comments
Post a Comment